These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14911309)

  • 1. POSSIBLE relationship between paralytic poliomyelitis and subcutaneous injection of immunizing agents and other medicinal substances.
    Pediatrics; 1952 Mar; 9(3):366-81. PubMed ID: 14911309
    [No Abstract]   [Full Text] [Related]  

  • 2. Further investigation into the association between immunizing injections and paralytic poliomyelitis.
    PEACH AM; RHODES AJ
    Am J Public Health Nations Health; 1954 Sep; 44(9):1185-8. PubMed ID: 13188983
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of prior injections of immunizing agents and of penicillin on the occurrence and severity of poliomyelitis.
    GREENBERG M; ABRAMSON H
    N Y State J Med; 1952 Nov; 52(21):2624-9. PubMed ID: 13002863
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunization status in paralytic poliomyelitis--a hospital based study.
    Srivastava VK; Laisram N; Srivastava RK
    Indian Pediatr; 1989 May; 26(5):430-3. PubMed ID: 2599610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication.
    Hennessey KA; Marx A; Hafiz R; Ashgar H; Hadler SC; Jafari H; Sutter RW
    J Infect Dis; 2000 Jul; 182(1):6-11. PubMed ID: 10882575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paralytic poliomyelitis in a rural area of north India.
    Varghese M; Qadeer I; Mohan D
    Natl Med J India; 1997; 10(1):8-10. PubMed ID: 9069697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis.
    Strebel PM; Ion-Nedelcu N; Baughman AL; Sutter RW; Cochi SL
    N Engl J Med; 1995 Feb; 332(8):500-6. PubMed ID: 7830731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic response to a booster injection following an early vaccination against poliomyelitis].
    BUTLER N
    Rev Immunol Ther Antimicrob; 1960; 24():249-50. PubMed ID: 13806504
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of Formaldehyde-inactivated Poliomyelitis Virus and Its Use as an Immunizing Agent in Cotton Rats.
    Loring HS; Schwerdt CE; Lawrence N; Anderson JC
    Science; 1947 Aug; 106(2744):104-5. PubMed ID: 17741052
    [No Abstract]   [Full Text] [Related]  

  • 10. Paralytic poliomyelitis--United States, 1980-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(4):79-83. PubMed ID: 9048844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral vaccines against poliomyelitis and vaccination-related paralytic poliomyelitis in Germany. Do we need a new immunization strategy?].
    Fescharek R; Arras-Reiter C; Arens ER; Quast U; Maass G
    Wien Med Wochenschr; 1997; 147(19-20):456-61. PubMed ID: 9471843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The precipitation of clinical poliomyelitis by injections.
    GOERKE LS
    Calif Med; 1951 May; 74(5):383-4. PubMed ID: 14848695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paralytic poliomyelitis (1989-1994): report from a sentinel center.
    Ahuja B; Gupta VK; Tyagi A
    Indian Pediatr; 1996 Sep; 33(9):739-45. PubMed ID: 9057401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-poliomyelitis vaccination with inactivated virus (Lepine vaccine). Effect of the booster injection on immunization].
    MARTIN R; ROGER F; DAMAS JP; ROGER A; JUILLARD P
    Bull Acad Natl Med; 1961 Nov 21-28; 145():664-73. PubMed ID: 14470436
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination against poliomyelitis in economically underdeveloped countries.
    Sabin AB
    Bull World Health Organ; 1980; 58(1):141-57. PubMed ID: 6966544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injections and paralytic poliomyelitis in tropical Africa.
    Guyer B; Bisong AA; Gould J; Brigaud M; Aymard M
    Bull World Health Organ; 1980; 58(2):285-91. PubMed ID: 6249510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2 1/2 Years of antipoliomyelitis vaccination (Lepine vaccine) at the Institut Pasteur hospital. Immunological results. Significance of the booster injection].
    MARTIN R; ROGER F; DAMAS JP; ROGER A
    Ann Inst Pasteur (Paris); 1959 Dec; 97():757-79. PubMed ID: 14421731
    [No Abstract]   [Full Text] [Related]  

  • 20. [History of development of the live poliomyelitis vaccine from Sabin attenuated strains in 1959 and idea of poliomyelitis eradication].
    Lashkevich VA
    Vopr Virusol; 2013; 58(1):4-10. PubMed ID: 23785754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.